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Abstract
 
Bronchus-associated lymphoid tissue (BALT) participates in airway immune responses. How-
ever, little is known about the lymphocyte–endothelial adhesion cascades that recruit lympho-
cytes from blood into BALT. We show that high endothelial venules (HEVs) in BALT express
substantial levels of VCAM-1, in marked contrast to HEVs in other secondary lymphoid tissues.
 
BALT HEVs also express the 
 
L
 
-selectin ligand PNAd. Anti–L-selectin, anti-PNAd, and
anti–LFA-1 mAbs almost completely block the homing of B and T lymphocytes into BALT,
whereas anti–
 
 
 
4
 
 integrin and anti–VCAM-1 mAbs inhibit homing by nearly 40%. 
 
 
 
4
 
 
 
7
 
 inte-
grin and MAdCAM-1 are not involved. Importantly, we found that mAbs against 
 
 
 
4
 
 integrin
and VCAM-1 significantly block the migration of total T cells (80% memory phenotype) but
not naive T and B cells to BALT. These results suggest that an adhesion cascade, which in-
cludes L-selectin/PNAd, 
 
 
 
4
 
 
 
1
 
 integrin/VCAM-1, and LFA-1, targets specific lymphocyte
subsets to BALT. This high level of involvement of 
 
 
 
4
 
 
 
1
 
 integrin/VCAM-1 is unique among
secondary lymphoid tissues, and may help unify lymphocyte migration pathways and immune
responses in BALT and other bronchopulmonary tissues.
Key words: lung • bronchi • cell adhesion molecules • endothelium • CD106
 
Introduction
 
Lymphocyte migration from the bloodstream into second-
ary lymphoid tissues is mandatory for maintaining immune
system homeostasis and providing efficient defense against
pathogens (1). Much of this migration occurs through high
endothelial venules (HEVs)
 
*
 
 and is regulated in part by
multistep cascades involving sequential lymphocyte/endo-
thelial adhesion and activation events (2–5). These cascades
differ from tissue to tissue, thus enabling certain subsets of
lymphocytes to migrate efficiently into specific lymphoid
tissues; this migration is partly controlled by tissue-selective
expression of endothelial adhesion molecules that bind to
ligands on circulating lymphocytes (6).
Bronchus-associated lymphoid tissue (BALT) consists of
discrete lymphoid aggregates found in the bronchial mu-
cosa in most mammals (7–9). Like other secondary lym-
phoid tissues such as lymph node (LN) and Peyer’s patch
(PP), BALT contains T cells, B cells, dendritic cells, mac-
rophages, and HEVs (9). Because BALT and intestinal
mucosa–associated PP show morphologic and functional
similarities, both were thought to belong to a general mu-
cosa-associated lymphoid system. For example, both BALT
and PP provide for the entry of mucosal pathogens through
special epithelial cells (M cells), and are involved in local
IgA production (9). However, differences have been noted
between BALT and PP. For example, in vitro lymphocyte/
endothelial binding studies suggest that BALT and PP
HEVs differ in their lymphocyte binding selectivity (10).
Although BALT clearly plays a role in pulmonary immune
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(650) 852-3369; Fax: (650) 858-3986; E-mail: ebutcher@stanford.edu
 
*
 
Abbreviations used in this paper:
 
 
 
BALT, bronchus-associated lym-
phoid tissue; CFSE, 5(6)-carboxyfluorescein diacetate succinimidyl
ester; HEV, high endothelial venule; IF, immunofluorescence; LN,
lymph node; MLN, mesenteric LN; NOD, nonobese diabetic; PLN,
peripheral LN; PP, Peyer’s patch; TRITC, tetramethylrhodamine-5-
(and-6)-isothiocyanate mixed isomers; WT, wild-type.T
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Lymphocyte Migration to BALT
 
responses, the multistep cascade that controls the migration
of lymphocytes to BALT, and the relationship of this cas-
cade to the lymphocyte 
 
 
 
4
 
 
 
1
 
/endothelial VCAM-1–domi-
nant cascade involved in lymphocyte homing to pulmonary
parenchyma, remain to be elucidated (11–15).
In this work, we explore the lymphocyte–endothelial
adhesion pathways that control the migration of lympho-
cytes from the bloodstream into BALT. We show that
BALT HEVs in nonobese diabetic (NOD), BALB/c, and
C57BL/6 mice coordinately display PNAd and VCAM-1
at a level not found on HEVs in other secondary lymphoid
tissues. Moreover, using adhesion-blocking mAbs in
short-term in vivo lymphocyte homing assays, we find that
L-selectin/PNAd, 
 
 
 
4
 
 
 
1
 
/VCAM-1, and LFA-1 adhesion
pathways are important in homing of specific lymphocyte
subsets to mouse BALT. Our results suggest that this dis-
tinctive combination of adhesion receptors helps form a
unique lymphocyte–endothelial cascade that is important in
lymphocyte subset recruitment to BALT and in broncho-
pulmonary immune responses.
 
Materials and Methods
 
Animals.
 
NOD, BALB/c, and C57BL/6 mice of both gen-
ders were purchased from Taconic or bred in our animal facility.
Only nondiabetic NOD mice were used in this paper. Sprague
Dawley rats and C57BL/6 Thy1.1 IgM
 
a
 
 mice were obtained
from The Jackson Laboratory. C57BL/6 
 
 
 
7
 
 integrin KO (
 
 
 
7
 
 KO)
mice are described previously (16). OVA TCR transgenic mice
(DO11.10) were obtained from Drs. D. Loh and O. Kanagawa
(Washington University, School of Medicine, St. Louis, MO),
and The Jackson Laboratory. All animals were housed under spe-
cific pathogen-free conditions in the Palo Alto Veterans Affairs or
Stanford University animal facilities.
 
Antibodies and Other Reagents.
 
mAbs used in this paper were
the following: anti-CD4 (GK1.5), anti-CD8 (53–6.7.2), anti-
 
 
 
4
 
(PS/2), anti–LFA-1 (FD441.8), and anti–ICAM-1 (BE29 and
YN1.7), grown from hybridomas obtained from the American
Type Culture Collection; anti–
 
 
 
4
 
 
 
7
 
 integrin heterodimer
(DATK32), anti-
 
 
 
7
 
 (FIB 504), anti–L-selectin (MEL-14), anti-
PNAd (MECA79), and anti–MAdCAM-1 (MECA367), grown
from hybridomas produced in our laboratory; anti-VCAM-1
(MK2.7, 4B12, 2A11.1 and 6C7.1, Dr. B. Engelhardt,
Max Planck Institute, Munster, Germany); anti-CD45R/B220
(RA3–6B2, Dr. R. Coffman, DNAX Research Institute, Palo
Alto, CA); anti-OVA TCR (KJ1–26, Dr. J. Kappler, National
Jewish Medical and Research Center, Denver, CO); anti–P-
selectin (RB40.34), anti–E-selectin (10E9.6), anti–ICAM-2 (3C4),
anti-CD44 (IM7), anti-Thy1.1 (OX-7), and anti-IgM
 
a
 
 (DS-1),
purchased from BD Biosciences; and anti-CD3 (KT3) from Ac-
curate Chemical. Rat anti–human CD44 (9B5; our laboratory)
and rat anti–mouse cerebellar antigen (OZ42; Dr. L. Pickford,
Coulter Pharmaceutical, Menlo Park, CA) were used as negative
control mAbs.
Biotin-anti–rat IgG, FITC-anti–rat IgG, and FITC-anti–rat
IgM were purchased from Vector Laboratories. Biotin-anti–rat
IgM and peroxidase-streptavidin were purchased from Jackson
ImmunoResearch Laboratories, whereas PE-anti–rat IgG came
from Biosource International. 3,3
 
 
 
-diaminobenzidine-tetrahy-
drochloride (DAB) was purchased from Sigma-Aldrich, while
5(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)
 
mixed isomers, tetramethylrhodamine-5(6)-isothiocyanate mixed
isomers (TRITC), and Alexa Fluor 488 were obtained from Mo-
lecular Probes.
 
Morphometric Analysis of BALT.
 
Mice were killed, and the
lungs filled with PBS/OCT (1:1) by intratracheal injection, re-
moved, and frozen in OCT. Frozen sections of the left lung were
stained with hematoxylin and eosin; slides that showed a longitu-
dinal section of a main bronchus that extended for at least one
half the length of the lung tissue were used for image analysis as
described previously (VAS II; Video Systems; reference 17). In
brief, we measured the area of all BALT aggregates and the bron-
chus on at least 20 nonsequential sections from each mouse. Re-
sults for each mouse are presented as the ratio of the BALT area
(mm
 
2
 
) to the bronchus area (mm
 
2
 
).
 
Immunohistochemistry.
 
Acetone-fixed frozen sections of lung,
peripheral LN (PLN), and PP were sequentially incubated with
hybridoma supernatant or purified mAb (1 h), biotin-anti–rat IgG
or biotin-anti–rat IgM Ab (30 min), peroxidase-streptavidin (30
min), and DAB solution (10 min). The slides were washed in
PBS after each incubation step. Some slides were counterstained
with hematoxylin or methylene blue.
 
Evaluation of Vascular Luminal VCAM-1 Expression.
 
100 
 
 
 
g
anti–VCAM-1 (4B12, 2A11.1, or 6C7.1) or negative control
(9B5) mAb was given intravenously to NOD and BALB/c mice
(8–15-mo-old). The mice were killed 3 min after injection and
perfused immediately with PBS through the right ventricle. Fro-
zen sections of lung, PLN, mesenteric LN (MLN), and PP were
incubated sequentially with 2 
 
 
 
g/ml PE-anti–rat IgG, PBS, 10%
normal rat serum, and Alexa 488–conjugated anti-PNAd, anti–
MAdCAM-1, or control mAb (10 
 
 
 
g/ml). We examined the
sections by confocal or immunofluorescence (IF) microscopy,
and determined how many HEVs in BALT, PLN, and MLN ex-
pressed both PNAd and VCAM-1, only PNAd, or only VCAM-
1. Similarly, we determined how many PP HEVs expressed both
MAdCAM-1 and VCAM-1, only MAdCAM-1, or only
VCAM-1.
 
T and B Cell Migration into BALT.
 
5 
 
  
 
10
 
7 
 
lymphocytes
from LN and spleen of C57BL/6 Thy1.1 IgM
 
a
 
 mice were trans-
ferred intravenously into each NOD host mouse (Thy1.2, IgM
 
b
 
;
 
 
 
8-mo old). Hosts were killed 2 h later; 10
 
6
 
 lymphocytes from
PLN, PP, MLN, spleen, and blood suspensions, as well as 10
 
6
 
 do-
nor lymphocytes used for the transfer (input cells), were incu-
bated for 30 min at 4
 
 
 
C in 100 
 
 
 
l of 0.5 
 
 
 
g/ml PE–anti-Thy1.1
and 1 
 
 
 
g/ml FITC–anti-IgM
 
a
 
 or isotype- and conjugation-
matched negative control mAbs. Two-color flow cytometry was
used as described previously to determine the percentage of cells
in the lymphocyte scatter gate that expressed Thy1.1 or IgM
 
a
 
(18). At least 5 
 
  
 
10
 
4 
 
cells in the lymphocyte gate were analyzed
on each sample. Frozen sections of host lungs stained with 2 
 
 
 
g/ml
PE–anti-Thy1.1 and 4 
 
 
 
g/ml FITC-anti-IgM
 
a
 
 mAbs were evalu-
ated by confocal microscopy; donor T and B cells in BALT were
counted on 
 
 
 
30 sections of lung from each mouse. Data are ex-
pressed as the ratio of donor T (Thy1.1
 
 
 
)/donor B (IgM
 
a 
 
 
 
) cells
in each tissue divided by the Thy1.1
 
 
 
/IgM
 
a 
 
 
 
 input ratio.
 
In Vivo Blocking of Lymphocyte Homing by Anti–adhesion Molecule
mAbs.
 
Lymphocytes from LN and spleen of 3–4-mo-old NOD
mice were labeled by incubating 2 
 
  
 
10
 
7
 
 cells/ml with 0.8 
 
 
 
g/ml
TRITC in labeling medium (50% RPMI 1640, 48.5% HBSS,
and 1.5% BCS) at 37
 
 
 
C for 15 min (19). Similarly, rat LN and
spleen lymphocytes were labeled with 4 
 
 
 
M CFSE as described
previously for TRITC (20). The cells were centrifuged through
BCS, washed, and resuspended in transfer medium (DMEM with
10 mM Hepes, and 1% BCS).T
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To block endothelial adhesion molecules, each host mouse re-
ceived 500 
 
 
 
g intravenously of anti–endothelial adhesion mole-
cule or control mAb, followed 30 min later by 5 
 
  
 
10
 
7
 
 TRITC-
labeled mouse cells intravenously. To block lymphocyte adhesion
molecules, TRITC-labeled mouse cells were treated with 10 
 
 
 
g/
ml anti–lymphocyte adhesion molecule or control mAb on ice
for 10 min; 5 
 
  
 
10
 
7
 
 mouse cells and 10
 
8
 
 CFSE-labeled rat cells
were transferred intravenously into each host. The rat cells,
which do not react with the anti–mouse lymphocyte adhesion
molecule mAbs used in these experiments, served as an internal
standard to control for differences between host mice in blood
flow to tissues and in the efficiency of the injection. An aliquot of
the labeled mouse and rat cell mixture was used to obtain the in-
put mouse/rat cell ratio. To ensure saturating mAb levels in vivo,
additional mAb (100 
 
 
 
g anti–endothelial or 250 
 
 
 
g anti–lym-
phocyte adhesion molecule) was given along with the donor cells.
In all experiments, host mice were killed 2 h after transfer. Stain-
ing with FITC-anti–rat IgG or IgM of tissues from host mice that
received anti–VCAM-1 or anti-PNAd mAb, and staining of lym-
phocyte suspensions from host mice that were given anti–LFA-1
mAb-coated lymphocytes showed that mAb was present on
mouse endothelia or lymphocytes, respectively, at the time of
sacrifice (unpublished data).
In experiments involving blocking of endothelial adhesion
molecules, flow cytometry was used to determine how many do-
nor cells were in host blood and how many donor cells had mi-
grated into host PLN, PP, MLN, and spleen. In brief, for each
cell suspension, we determined the absolute number of donor
cells (TRITC
 
 
 
) and total cells in the lymphocyte scatter gate; at
least 5 
 
  
 
10
 
4
 
 total gated cells were analyzed for each sample. We
calculated donor cells as a percentage of total gated cells in each
tissue. The donor cells in BALT were observed by confocal mi-
croscopy, and homed cell density was calculated as the number of
donor cells/10
 
3
 
 
 
 
 
m
 
2
 
 of BALT. At least 30 sections of lung were
evaluated per mouse. For each tissue, results for each specific
mAb treatment are expressed as percent homing in control mAb-
treated host mice.
In experiments involving blocking of lymphocyte adhesion
molecules, the numbers of donor mouse (TRITC
 
 
 
) and internal
standard rat (CFSE
 
 
 
) cells were evaluated in host PLN, PP,
MLN, spleen, and blood by two-color flow cytometry and in
BALT by confocal microscopy. The donor mouse/internal stan-
dard cell ratios for all tissues were normalized by the input
mouse/internal standard cell ratio. For each tissue, results for each
specific mAb treatment are expressed as percent homing of con-
trol mAb-treated cells.
In preliminary experiments, we compared data in PLN, PP,
and MLN obtained by flow cytometry and confocal microscopy
and confirmed that there is a good correlation between the two
assays (r 
 
  
 
0.97; unpublished data).
 
Homing of Lymphocytes from 
 
 
 
7
 
 KO Mice.
 
LN and spleen lym-
phocytes from 3–4-mo-old C57BL/6 
 
 
 
7
 
 KO and C57BL/6
wild-type (WT) mice were labeled with TRITC and CFSE, re-
spectively, and injected intravenously into NOD mice (5 
 
  
 
10
 
7
 
of each cell type per mouse). Numbers of donor cells in PLN, PP,
MLN, spleen, blood, and BALT were determined as described
previously. The results are presented as the ratio of 
 
 
 
7
 
 KO/WT
lymphocytes in each tissue divided by the 
 
 
 
7
 
 KO/WT input ra-
tio.
 
Naive T Cell Homing.
 
We prepared lymphocyte suspensions
of LN and spleen from 6-wk-old DO11.10 OVA TCR trans-
genic mice and age-matched C57BL/6 Thy1.1 mice. The
DO11.10 T cells have a naive phenotype, whereas the C57BL/6
 
Thy1.1 T cells, which are a mix of naive and memory cells,
served as internal standards. 5 
 
  
 
10
 
7 
 
DO11.10 lymphocytes and
an equal number of C57BL/6 Thy1.1 lymphocytes were trans-
ferred intravenously into each NOD mouse. 2 h later, mice were
killed and lymphocyte suspensions from PLN, PP, MLN, spleen,
and blood were stained with 2 
 
 
 
g/ml FITC-anti–OVA TCR
(KJ1–26) and 0.5 
 
 
 
g/ml PE–anti-Thy1.1 mAbs; donor DO11.10
naive T cells (OVA TCR
 
 
 
) and internal standard C57BL/6 T
cells (Thy1.1 ) were detected by flow cytometry as described
earlier in Materials and Methods. Frozen sections of lung stained
with 4  g/ml FITC-KJ1–26 and 2  g/ml PE–anti-Thy1.1 mAbs
were examined by confocal microscopy for DO11.10 and inter-
nal standard T cells in BALT. Data are expressed as the ratio of
OVA TCR  (naive)/Thy1.1  (internal standard) T cells in
BALT, PLN, PP, MLN, and blood normalized for their ratio in
the spleen.
To evaluate the roles of PNAd,  4, and VCAM-1 in the hom-
ing of total T cells, naive T cells, and B cells to BALT, 5   107
lymphocytes from 6-wk-old DO11.10 mice (KJ1–26  naive T
cells, IgMa  B cells) or 19-mo-old C57BL/6 Thy1.1 mice were
transferred intravenously into NOD host mice; as described ear-
lier in Materials and Methods, the host mice were treated with
anti-PNAd or anti–VCAM-1 mAb, or the donor cells with anti-
 4 mAb, before the transfer. Host mice were killed and their
lymphoid tissues were stained with a FITC-conjugated mAb
against OVA TCR, IgMa, or Thy 1.1, and evaluated as described
earlier in Materials and Methods. The results for the specific
mAb treatment are presented as percent homing of the control
mAb treatment.
Data Analysis. Data are given as mean   SE for each group.
One-way analysis of variance (ANOVA) was used for statistical
analysis unless otherwise indicated. P   0.05 is considered to be
statistically significant.
Results
BALT and Its Lymphocyte Subsets in NOD, BALB/c, and
C57BL/6 Mice. To define the best mouse strains for the
study of lymphocyte migration to BALT, we examined
histologic sections of lungs from adult mice of several
strains and ages (6 wk–2 yr). We found BALT in most old
( 1 yr), but not young, BALB/c and C57BL/6 mice. In
contrast, BALT was easily identified in most NOD mice,
especially those older than 7 mo. Tissue section mor-
phometry of lung sections from 1-yr-old NOD, BALB/c,
and C57BL/6 mice showed that NOD mice had the most
abundant BALT, with a BALT area (mm2) to bronchus
area (mm2) ratio of 0.12   0.02 (mean   SE), followed by
BALB/c mice (Fig. 1; 0.08   0.02). C57BL/6 WT and
C57BL/6  7 KO mice had the least BALT (0.05   0.02
and 0.04   0.01, respectively; P   0.05, C57BL/6 KO
compared with NOD and BALB/c). There were no dif-
ferences in BALT area between female and male mice
(unpublished data).
NOD BALT, like BALB/c and C57BL/6 BALT, was
composed predominantly of small lymphocytes without
germinal centers. We stained frozen sections of lungs from
these mice with mAbs against B cells, T cells, and T cell
subsets. In most BALT aggregates, B cells outnumbered T
cells; most of the T cells were CD4  (Fig. 2). ProminentT
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1258 Lymphocyte Migration to BALT
HEVs were seen in BALT from all strains. Because NOD
BALT is easily found, but shows similar histology and cel-
lular composition to BALT from other strains, we used
NOD mice as our main model to study the adhesion cas-
cades that control lymphocyte migration to BALT.
T and B Cells Migrate from Blood into BALT. We ini-
tially compared the efficiency of homing of T versus B cells
from the bloodstream into BALT. For this purpose, lym-
phocytes from C57BL/6 Thy1.1 IgMa mice were trans-
ferred intravenously into NOD (Thy1.2, IgMb) mice. Do-
nor T and B cells in host lymphoid tissues and blood were
detected by staining with PE–anti-Thy1.1 and FITC–anti-
IgMa mAbs, followed by flow cytometry or confocal mi-
croscopy. The relative abilities of T and B cells to migrate
into each lymphoid tissue were determined by normalizing
the T/B cell ratio in the tissue by the input T/B cell ratio.
We found that T cells homed much more efficiently than
B cells to BALT and PLN, with normalized T/B cell hom-
ing ratios of 3.3 for BALT and 6.6 for PLN (Fig. 3). T cells
migrated slightly better than B cells to PP and MLN with
normalized T/B cell ratios of 1.3 and 1.4, respectively.
However, B cells migrated more efficiently than T cells to
spleen with the ratio of 0.5. Thus, the pattern of T versus B
cell recruitment by BALT seems intermediate between that
of PLN and PP.
Expression of Lymphocyte and Endothelial Adhesion Mole-
cules in BALT. The functional and histologic similarities
between BALT and PP, including the presence of HEVs,
led us to hypothesize that lymphocytes home to BALT us-
ing lymphocyte–endothelial adhesion pathways similar to
those used in PP and other secondary lymphoid tissues. To
address this hypothesis, we stained frozen sections of
BALT, PLN, and PP with mAbs against several lympho-
cyte and endothelial adhesion molecules that are involved
in lymphocyte migration into secondary lymphoid tissues
(1). These include the following: lymphocyte L-selectin
and endothelial PNAd, which play a major role in migra-
tion of naive lymphocytes into PLN and a minor role in
such migration into PP (3, 5, 21, 22); lymphocyte  4 7 and
endothelial MAdCAM-1, which mediate lymphocyte mi-
Figure 1. Prominence of BALT
in various mouse strains. BALT
and bronchial areas (mm2) were
determined by morphometric
analysis of lung sections from 1-yr-
old NOD (n   6), BALB/c (n  
5), C57BL/6 WT (n     4), and
C57BL/6  7 integrin KO (n   4)
mice. BALT was significantly
more abundant in NOD and
BALB/c mice than in C57BL/6
KO mice (*, P   0.05 compared
with NOD and BALB/c, Mann-
Whitney test). Data for each group
are given as mean   SE.
Figure 2. Lymphocyte subsets in BALT. Frozen sections of lung from
NOD (A, C, E, G, and I), BALB/c (B, D, F, H, and J), and C57BL/6
(not depicted) mice were stained with hematoxylin and eosin (A and B),
or anti-B220 (C and D), anti-CD3 (E and F), anti-CD4 (G and H), and
anti-CD8 (I and J) mAbs. There was no staining using isotype control
mAbs (not depicted). (Arrows indicate BALT; Br is in bronchial lumen;
C–J, immunoperoxidase stains; original magnification   20.)
Figure 3. T and B cell migra-
tion to BALT. Lymphocytes
from C57BL/6 Thy1.1  IgMa 
mice were transferred intrave-
nously into NOD mice
(Thy1.2  IgMb ). Host lym-
phoid tissues and blood were
stained with PE–anti-Thy1.1 
(donor T cells) and FITC–anti-
IgMa (donor B cells) mAbs, fol-
lowed by flow cytometry or
confocal microscopy. Results are
presented as the ratio of T to B
cells migrating into each organ, normalized by dividing by the T / B cell
input ratio (mean   SE). Data from three hosts indicate that T cells mi-
grate to BALT more efficiently than do B cells. (**, P   0.01, BALT
[gray bar] compared with PLN, PP, MLN, or spleen [white bars]).T
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1259 Xu et al.
gration into intestinal lymphoid tissues such as PP and lam-
ina propria (3, 22, 23); and lymphocyte LFA-1 and endo-
thelial ICAM-1, which are involved in lymphocyte
migration into most secondary lymphoid tissues and sites of
chronic inflammation (24–26). We also examined BALT
for expression of adhesion molecules that mediate lympho-
cyte homing mainly to sites of chronic inflammation; these
molecules include VCAM-1, which is expressed by endo-
thelia in a wide variety of chronically-inflamed tissues, and
its lymphocyte ligands  4 1 and  4 7 (11–15, 27–30).
Immunohistochemical stains showed that the patterns of
endothelial adhesion molecule expression in NOD mice
(Fig. 4) were identical to those in BALB/c and C57BL/6
mice (not depicted). Specifically, anti-PNAd mAb gave
strong staining of HEVs in BALT (Fig. 4 B) and PLN,
whereas weak staining was observed on HEVs in PP.
Anti–MAdCAM-1 mAb gave no staining of HEVs in
BALT (Fig. 4 C) and PLN, and strong staining of HEVs in
PP. BALT HEVs stained strongly for ICAM-1 and
ICAM-2 (not depicted). There was no staining of HEVs
in BALT for E- or P-selectin, although there was strong
staining of vessels in the positive control slide of inflamed
tongue. There was no staining of BALT HEVs by isotype
control mAbs.
Immunohistochemistry showed staining for VCAM-1
on BALT HEVs (Fig. 4 D), but no staining above back-
ground on PLN and PP HEVs (not depicted). However,
previous papers indicate that VCAM-1 expression is not
restricted to endothelia; it is expressed by a variety of cells
and extracellular structures, including pericytes and con-
nective tissues that form the perivascular sheaths surround-
ing some HEVs (31). Thus, to determine whether BALT
HEVs display VCAM-1 on the endothelial luminal surface,
where the VCAM-1 would be available to bind its lym-
phocyte ligands, we injected anti–VCAM-1 or negative
control mAb intravenously into NOD and BALB/c mice
(n   5 mice of each strain). Mice were killed 3 min after
injection, and sections were prepared from lung, PLN,
MLN, and PP. These sections were stained with PE-anti–
rat IgG (to detect injected mAb) and an Alexa 488–conju-
gated mAb against a vascular addressin (PNAd in BALT,
PLN, and MLN; MAdCAM-1 in PP). Sections were ex-
Figure 4. PNAd and VCAM-1, but not MAdCAM-1, are expressed
by BALT HEVs. Serial frozen sections of lung from a 1-yr-old NOD
mouse were stained with hematoxylin and eosin (A), or anti-PNAd (B),
anti–MAdCAM-1 (C), and anti–VCAM-1 (D) mAbs. There was no
staining using isotype control mAbs (not depicted). (Arrows indicate
HEV; B–D, immunoperoxidase stains; original magnification   20.)
Table I. VCAM-1 Is Expressed on the Endothelial Luminal Surface of Almost all HEVs in BALT and on Rare HEVs in Other Secondary 
Lymphoid Tissues
NOD BALB/c
Tissue Addressin onlya VCAM-1 only Dual expression Addressin onlya VCAM-1  only Dual  expression 
%%% % % %
BALT 6.2   1.1 2.6   1.2 91.2   1.9b 6.4   1.2 3.0   1.7 90.6   2.0b
PLN 94.6   1.8 0.4   0.2 5.0   1.8 95.4   2.3 0.6   0.4 4.0   2.1
MLN 94.8   2.9 1.0   0.6 4.3   2.7 96.2   3.3 0.2   0.2 3.6   3.1
PP 98.3   0.6 0.0   0.0 1.8   0.6 74.2   17.6 0.8   0.8 9.0   3.0
Five NOD and five BALB/c mice were injected intravenously with anti–VCAM-1 mAb. The numbers of HEV that expressed addressin only, luminal
VCAM-1 only, or both were determined by tissue section IF staining and confocal or IF microscopy. Results are expressed as mean   SE.  Mean
number of HEV examined in each tissue in each mouse: BALT   29, PLN   182, MLN   72, and PP   41. 
aAddressin   PNAd for BALT, PLN and MLN; MAdCAM-1 for PP.  
bIn each strain, the percentage of BALT HEVs with dual expression was significantly greater than the percent of PLN, MLN, and PP HEVs with
dual expression (P   0.001, unpaired t test). There were no differences between the two strains in the patterns of adhesion molecule expression by
BALT HEVs.T
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1260 Lymphocyte Migration to BALT
amined by confocal or IF microscopy for luminal expres-
sion of VCAM-1 by HEVs.
In BALT,  90% of HEVs showed dual expression of
PNAd and luminal VCAM-1 (Table I and Fig. 5, A and
C); in contrast, 5% or fewer of HEVs in PLN and MLN
coexpressed these molecules (Table I and Fig. 5, B and D).
PE-anti–rat IgG did not stain HEVs of mice that received
the negative control mAb (Fig. 5, E and F). Thus, the de-
gree of endothelial expression of VCAM-1 clearly distin-
guishes HEVs in BALT from those in other secondary
lymphoid tissues.
We also used immunohistochemistry to examine the ex-
pression of lymphocyte adhesion molecules in BALT,
PLN, and PP of NOD, BALB/c, and C57BL/6 mice.
Most lymphocytes in these tissues stained with antibodies
against L-selectin,  4, and  7 (unpublished data). We did
not note any qualitative differences in the expression of
these lymphocyte adhesion molecules between strains or
tissues. Our findings that BALT lymphocytes express adhe-
sion molecules similar to those expressed by naive lympho-
cytes in PLN and PP suggest that many BALT lymphocytes
are of naive phenotype.
Figure 5. VCAM-1 and PNAd
are coexpressed on BALT HEVs.
NOD and BALB/c mice were
injected intravenously with anti–
VCAM-1 (A–D) or negative
control (9B5) mAb (E and F).
Sections of BALT (A, C, and E)
and PLN (B, D, and F) were
stained with PE-anti–rat IgG Ab
(red) to detect injected mAb and
Alexa 488–anti-PNAd mAb
(green) to detect HEVs. Sections
(A–D) were evaluated by confo-
cal or IF microscopy for HEV
expression of VCAM-1 and
PNAd. All BALT HEVs (ar-
rows) in NOD (A) and BALB/c
(C) mice coexpress VCAM-1
and PNAd, whereas rare PLN
HEVs (arrow) in NOD (B) and
BALB/c (D) mice show coex-
pression. There is no red fluores-
cence on HEVs in BALT and
PLN of NOD mice that were
given the negative control mAb
(9B5; E and F). (White line out-
lines BALT; arrows point to
some of the HEVs that are dual
positive for VCAM-1 and
PNAd; arrowheads indicate
VCAM-1–expressing vessels out-
side the lymphoid tissue; BALT
original magnification   20 [A,
C, and E]; PLN original magnifi-
cation   10 [B, D, and F].)T
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1261 Xu et al.
Critical Role of the L-selectin/PNAd Pathway in Lymphocyte
Homing to BALT. The strong expression of PNAd by
BALT HEVs led us to hypothesize that PNAd is important
in lymphocyte homing to BALT. To test this hypothesis,
we used short-term in vivo lymphocyte homing assays to
investigate the effects of adhesion blocking mAbs against
PNAd (MECA79) and its lymphocyte ligand L-selectin
(MEL-14) on homing of donor LN and spleen lympho-
cytes from blood into host BALT. The homing of the do-
nor lymphocytes into BALT was strikingly reduced by
MECA79 treatment compared with control mAb treat-
ment of host mice (Fig. 6 A and Fig. 7, A and B; P  
0.01), and by MEL-14 treatment compared with control
mAb treatment of donor lymphocytes (Fig. 6 B and Fig. 7,
C and D; P   0.01). As expected, both specific mAbs al-
most completely inhibited migration of lymphocytes into
PLN, and partially inhibited migration into MLN and PP
(Fig. 6, A and B). These results demonstrate that the
L-selectin–PNAd pathway is critical for lymphocyte hom-
ing to BALT.
 4 and VCAM-1 Contribute to Lymphocyte Migration to
BALT. The expression of VCAM-1 by BALT HEVs
suggests that lymphocytes may migrate to BALT using
 4 1/VCAM-1 and/or  4 7/VCAM-1 adhesion path-
ways. Short-term in vivo homing assays showed that anti–
VCAM-1 mAb (4B12) blocked lymphocyte homing to
NOD BALT by 39% (Fig. 6 C; P   0.05 as compared with
control mAb) and to BALB/c BALT by 44% (P   0.05;
not depicted), but did not significantly block homing to
MLN, PLN, and PP. Similar to the anti–VCAM-1 block-
ing effect, anti- 4 mAb (PS/2) blocked lymphocyte hom-
ing into NOD BALT by  40% (Fig. 6 D; P   0.05). As
expected, anti- 4 mAb blocked lymphocyte homing to PP
and MLN by 80% and 40%, respectively (P   0.01).
LFA-1 Is Involved in Lymphocyte Homing to BALT. Our
in vivo homing assays showed that blockade of LFA-1–
inhibited lymphocyte homing to BALT by 97% (Fig. 6 E,
P   0.01; Fig. 7, E and F). As expected, anti–LFA-1 mAb
also blocked most of the lymphocyte homing to PLN, PP,
and MLN (Fig. 6 E; P   0.01 for PLN and MLN, P  
0.05 for PP). Associated with decreased migration into sec-
ondary lymphoid tissues, donor mouse lymphocyte levels
were elevated in blood. These results indicate that LFA-1 is
essential for lymphocyte homing to BALT.
 4 7 Does Not Contribute to Lymphocyte Homing to
BALT. The absence of staining for MAdCAM-1 on
BALT HEVs suggests that lymphocyte homing to BALT
does not use the  4 7/MAdCAM-1 adhesion pathway. In
in vitro experimental systems, however,  4 7 can bind to
VCAM-1 and MAdCAM-1 (6). We performed several ex-
periments to address the potential role of  4 7 in lympho-
cyte homing to BALT. First, our in vivo migration studies
showed that anti- 4 7 mAb (DATK32) had no effect on
lymphocyte homing to BALT, although it significantly
blocked lymphocyte homing to MLN and PP (Fig. 8 A;
P   0.01). Second, we found that lymphocytes from  7
KO and WT mice migrated equally well into BALT. As
expected, the  7 integrin–deficient lymphocytes migrated
poorly to PP and MLN (Fig. 8 B; P   0.01). Third, to see
if BALT develops normally in  7 KO mice, we examined
histologic sections of lungs from these mice. There were
no significant differences in BALT area (Fig. 1) or mor-
phology between  7 KO and WT mice (not depicted).
Together, these data demonstrate that neither  4 7/MAd-
CAM-1 nor  4 7/VCAM-1 contributes to lymphocyte
homing to BALT.
 4 Integrin and VCAM-1 Recruit Memory T Cells to
BALT. We wished to determine if naive T cells migrate
to BALT and, if so, which adhesion pathways are involved.
To do this, we used DO11.10 OVA TCR transgenic mice.
Figure 6. Antibodies to PNAd, L-selectin, VCAM-1,  4 integrin, and
LFA-1 inhibit lymphocyte homing to BALT. (A and C) TRITC-labeled
mouse lymphocytes were transferred intravenously into NOD mice
treated with test mAb or control mAb. (B, D, and E) TRITC-labeled
mouse lymphocytes treated with test mAb or control mAb were trans-
ferred with CFSE-labeled rat internal standard lymphocytes into NOD
mice. Donor cells in host lymphoid tissues were detected by flow cytom-
etry or confocal microscopy and homing was assessed as described in Ma-
terials and Methods. Values represent the efficiency of homing compared
with that of control mAb-treated cells (100%) (mean   SE; n   3 mice/
group). (A) Anti-PNAd mAb almost completely blocks lymphocyte
homing to BALT and PLN and partially blocks homing to PP and MLN.
(B) Anti–L-selectin mAb strikingly inhibits lymphocyte homing to BALT
and PLN, and partially inhibits homing to PP and MLN. Anti–VCAM-1
(C) and anti– 4 integrin (D) mAbs partially inhibit lymphocyte homing
to BALT. (E) LFA-1 is essential for lymphocyte homing to BALT. *, P  
0.05 and **, P   0.01 compared with control mAb group.T
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1262 Lymphocyte Migration to BALT
In young unimmunized DO11.10 mice, the T cells have a
naive phenotype. Thus, when these lymphocytes are trans-
ferred into a host mouse, anti–OVA TCR mAb (KJ1–26)
can be used to identify naive T cells in tissues (32). We
transferred lymphocytes from 6-wk-old DO11.10 mice
along with an equal number of internal standard lympho-
cytes (including mixed memory and naive T cells) from
6-wk-old C57BL/6 Thy1.1 mice into NOD mice. To as-
sess homing of naive T cells to different lymphoid tissues,
we compared the OVA TCR/Thy1.1 T cell ratios in each
tissue with the OVA TCR/Thy1.1 T cell ratio in spleen.
The ratios in BALT, LN, and PP did not differ significantly
Figure 7. Anti-PNAd, L-selec-
tin, and LFA-1 blockade of
lymphocyte homing to BALT
revealed by IF histology.
TRITC-labeled mouse lympho-
cytes were transferred intrave-
nously with or without CFSE-
labeled internal standard rat
lymphocytes into NOD mice.
Lymphocytes that homed to
BALT were observed and pho-
tographed at 40 magnification by
confocal microscopy. All micro-
graphs are two color; red and
green cells are homed donor
mouse and rat lymphocytes, re-
spectively. Anti-PNAd mAb (A)
inhibits donor mouse lympho-
cyte homing to BALT, as com-
pared with a negative control
mAb (B). Anti–L-selectin mAb
(C) inhibits donor mouse lym-
phocyte homing to BALT, as
compared with a negative con-
trol mAb (D). Anti–LFA-1 mAb
(E) blocks donor mouse lympho-
cyte homing to BALT, as com-
pared with a negative control
mAb (F).T
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1263 Xu et al.
from that in spleen, indicating that BALT, like the other
secondary lymphoid tissues, can efficiently recruit naive T
cells from the blood (Fig. 9 A). A small but significant dif-
ference (P   0.05) was observed between BALT and PP,
suggesting that, relative to the OVA TCR  naive T cells,
cells in the Thy 1.1  population (presumably memory T
cells) migrate somewhat better to BALT than to PP.
PNAd is known to be important in the homing of naive
T cells to PLN and PP, whereas the  4–VCAM-1 pathway
is thought mainly to recruit memory T cells to inflamma-
tory sites (6). The ability of anti- 4 and anti–VCAM-1
mAbs to partially inhibit homing of bulk populations of LN
and spleen lymphocytes to BALT (Fig. 6) may result from
effects on naive T cells, memory T cells, and/or B cells.
Thus, we investigated the ability of anti- 4 and anti–
VCAM-1 mAbs to block the migration of B cells, naive T
cells (from young DO11.10 mice), and total T cells (from
old C57BL/6 mice; 80% of CD4 and CD8 cells had a
CD44high memory phenotype) into BALT. B cells, naive T
cells, and total T cells were detected in host tissues by stain-
ing with anti-IgMa, anti–OVA TCR, and anti-Thy 1.1
mAbs, respectively. Anti–VCAM-1 and anti- 4 mAbs did
not significantly inhibit B and naive T cell recruitment to
BALT (Fig. 9 B); in contrast, anti-PNAd mAb blocked
92% of naive T cell migration to BALT (not depicted).
Anti- 4 and anti–VCAM-1 mAbs each blocked  70% of
memory T cell–rich total T cell migration to BALT (Fig. 9
B; P   0.01). Anti–VCAM-1 mAb did not significantly in-
hibit the migration of B cells and total T cells to MLN,
PLN, and PP (not depicted). Thus,  4 and VCAM-1 are
likely to recruit  4 1
  memory T cells to BALT, but not
to LN or PP.
Discussion
Mice as a Model for Investigation of Lymphocyte Migration to
BALT. To study lymphocyte migration to BALT, it is
important to use animal models with readily detectable
BALT. The prominence of BALT depends on species, age,
antigen stimulation, and the presence or absence of bron-
chopulmonary disease or systemic autoimmune disorder (8,
9, 33–36). Although guinea pigs, rabbits, and rats have
well-developed BALT, the lack of immunological reagents
that react with lymphocyte and endothelial adhesion mole-
cules in these animals limits their usefulness for lymphocyte
migration experiments (7, 8). In this work, we found that
the presence of BALT also depends on the strain: BALT
develops earlier and is more extensive in NOD than in
BALB/c and C57BL/6 mice (Fig. 1). NOD mice are a
model for autoimmune-mediated (type 1) diabetes and
Sjogren’s syndrome; these mice develop lymphoid infil-
trates in pancreatic islets and several other tissues including
salivary and lacrimal glands (27, 30, 37). Thus, it is possible
that NOD BALT is stimulated or different from BALT in
nonautoimmune-prone mice. However, we found no dif-
ferences in BALT histology (except for size; Fig. 1), lym-
phocyte subset composition, and lymphocyte and endothe-
lial adhesion molecule expression between NOD, BALB/c,
and C57BL/6 mice.
PNAd and VCAM-1, but Not MAdCAM-1, Are Ex-
pressed by BALT HEVs. We demonstrate that BALT
HEVs have a distinctive pattern of endothelial adhesion
molecule expression: they are PNAd , MAdCAM-1 , and
VCAM-1 . Moreover, we show that VCAM-1 is ex-
pressed on the endothelial luminal surface of  90% of
BALT HEVs. The strong luminal expression of VCAM-1
in BALT HEVs is unique among secondary lymphoid tis-
sues. Although VCAM-1 has been detected in association
with HEVs in mouse and rat LN and PP and human ton-
sils, the luminal endothelial staining in these HEVs is mini-
Figure 8.  4 7 is not involved in lymphocyte homing to BALT. (A)
Anti- 4 7 mAb does not block lymphocyte homing to BALT. (B) Lym-
phocytes from  7 integrin KO mice home normally to BALT. There
were 3–4 mice in each group. **, P   0.01 compared with control group
where the value was set to 100%.
Figure 9. VCAM-1 and   4
integrin are likely involved in
memory T cell migration to
BALT. (A) Naive T cells from
6-wk-old OVA TCR trans-
genic DO11.10 mice were trans-
ferred with equal numbers of
age-matched internal standard
C57BL/6 Thy1.1  lymphocytes
into NOD Thy1.2  mice. Do-
nor T cells were detected in host
tissues by staining with FITC-
anti–OVA TCR (clone KJ1–26)
and PE–anti-Thy1.1 mAbs, fol-
lowed by flow cytometry or
confocal microscopy. Results are
presented as the ratio of naive
KJ1–26  to internal standard
Thy1.1  T cells in each tissue,
normalized by the ratio homed
to spleen (mean   SE). Data
from three hosts show that naive
T cells (OVA TCR ) migrate as
well as C57BL/6 T cells (a mix-
ture of naive and memory cells)
to different organs (no significant
differences between spleen and
BALT, PLN, PP, and MLN; *,
P   0.05, BALT compared with PP). (B) B and naive T cells from 6-wk-
old DO11.10 mice and total T cells (80% memory phenotype) from 19-
mo-old C57BL/6 Thy 1.1 mice were transferred intravenously into
NOD mice. Anti- 4 and anti–VCAM-1 mAbs inhibited the migration of
memory-enriched total T cells, but not naive T cells or B cells, to BALT
(**, P   0.01, compared with control mAb).T
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1264 Lymphocyte Migration to BALT
mal compared with that of BALT HEVs (our results; 26,
31, 38).
The findings in BALT are interesting in relationship to
recent papers on the expression of adhesion molecules by
HEVs in other mucosal lymphoid tissues. For example,
HEVs in mouse PP express MAdCAM-1, low levels of
PNAd, and very little luminal VCAM-1 (our results; 22,
23, 39); HEVs in mouse nasal-associated lymphoid tissue
express PNAd alone or with MAdCAM-1, but not
VCAM-1 (40); HEVs in human tonsil express PNAd, but
neither MAdCAM-1 nor luminal VCAM-1 (31, 41, 42);
and MAdCAM-1 is not expressed on HEVs in human con-
junctiva-associated lymphoid tissue (43). Thus, HEVs in
mucosal lymphoid tissues at specific anatomic sites show
unique patterns of adhesion molecule expression: in combi-
nation with specialized expression of chemokines and other
activating factors, this may allow the selective targeting of
lymphocytes to specific mucosal sites, thus enhancing the
efficiency of local immune surveillance and responses.
L-selectin and PNAd Recruit Lymphocytes to BALT. In
this paper, we demonstrate that anti–L-selectin and anti-
PNAd mAbs almost completely inhibit homing of LN and
spleen lymphocytes from blood into BALT. We also show
that naive T cells migrate to BALT and that most of this
migration is blocked by anti-PNAd mAb. We conclude
that the specific recognition of PNAd on BALT HEVs by
lymphocyte L-selectin plays a vital role in targeting lym-
phocytes, including naive T cells, to BALT.
 4 1 and VCAM-1 Mediate Lymphocyte Migration to
BALT. We demonstrate that VCAM-1 is expressed on
the luminal surface of HEVs in BALT, at a level much
higher than on HEVs in other secondary lymphoid tissues.
Our in vivo migration assays show that anti- 4 and anti–
VCAM-1 mAbs inhibit  40% of bulk lymphocyte homing
to BALT, whereas anti–VCAM-1 has no significant effect
on homing to PLN, PP, and MLN. We also show that nei-
ther mAb inhibits the homing of B or naive T cells to
BALT. In contrast, we found that inhibition of  4 or
VCAM-1 blocks the homing of total T cells (80% memory
phenotype) from old mice into BALT, suggesting that
these adhesion molecules are mainly involved in the re-
cruitment of  4 1
  memory T cells to BALT. Published
studies indicate that  4 1 and VCAM-1 mediate the migra-
tion of memory/effector cells to inflamed lung (11–15, 46).
Thus,   4 1/VCAM-1 may also support recruitment of
bronchopulmonary memory T cells from blood into
BALT, where these memory cells can meet airway antigens
taken up by BALT.
Berlin-Rufenach et al. reported that VCAM-1 contrib-
utes to lymphocyte homing to LN (26). Consistent with
our work, however, their published histology shows pre-
dominantly abluminal staining for VCAM-1 on LN HEVs.
Moreover, they and others found that anti–VCAM-1
mAbs did not inhibit homing of lymphocytes to LN and
PP (our results; 22, 44, 45) unless LFA-1 was absent or
blocked (26). Thus, a functional role for VCAM-1 in lym-
phocyte migration to LN and PP could only be revealed
when the dominant LFA-1 pathway was inhibited or miss-
ing. In contrast to LN and PP, we find that lymphocyte
homing to BALT involves  4 and VCAM-1, but not  4 7,
and is easily detectable in standard in vivo homing assays.
These findings indicate that  4 1 and VCAM-1 contribute
much more prominently in lymphocyte homing to BALT
than to other secondary lymphoid tissues.
 4 7 and MAdCAM-1 Are Not Required for Lymphocyte
Homing to BALT. In this work, we found that: a) MAd-
CAM-1 is not expressed by BALT HEVs; b)  4 7 is not
required for migration of lymphocytes into BALT; and c)
BALT in WT mice is histologically indistinguishable from
BALT in  7 KO mice. These results indicate that the  4 7/
MAdCAM-1 adhesion system is not involved in lympho-
cyte migration into BALT. Thus, the  4 7/MAdCAM-1
pathway is not required for lymphocyte homing to all mu-
cosal secondary lymphoid tissues; instead, its involvement
and that of  4 1/VCAM-1 help distinguish the mecha-
nisms of lymphocyte migration to specific mucosal sites.
LFA-1 Is Essential for Lymphocyte Homing to BALT.
We found that anti–LFA-1 mAb almost completely blocks
lymphocyte homing to BALT and LN, and partially blocks
homing to PP. This is in agreement with previous studies
showing that LFA-1 is essential for activation-dependent
adhesion of lymphocytes to PLN and PP HEVs (3, 5, 24–
26). It is likely that LFA-1 mediates lymphocyte homing to
BALT through similar mechanisms.
Multistep Cascades for Lymphocyte Homing to PP and
BALT. Lymphocyte migration from blood into second-
ary lymphoid tissues is not a random process; it is con-
trolled by highly specific interactions between lymphocytes
and HEV endothelial cells in these tissues. These interac-
tions consist of multistep cascades with at least four sequen-
tial adhesion and activation steps, including lymphocyte
tethering and rolling (step 1); lymphocyte activation by
chemokines or other activating molecules (step 2); activa-
tion dependent arrest or firm adhesion (step 3); and diaped-
esis into tissues (step 4). The adhesion cascades that govern
the migration of naive lymphocytes into PLN and PP have
been defined by in situ microscopy studies (3, 5). The data
from our paper suggest that the adhesion cascades in BALT
may parallel those in PP, but with  4 1/VCAM-1 interac-
tion in BALT serving the role of  4 7/MAdCAM-1 inter-
action in PP.
In PP HEVs, lymphocytes tether and roll (step 1) by
lymphocyte L-selectin binding to carbohydrate epitopes on
endothelial MAdCAM-1 and by lymphocyte  4 7 binding
to MAdCAM-1 (3, 47). The chemokine/chemokine re-
ceptor pairs CCL21 (SLC/6Ckine)/CCR7 and CXCL12
(SDF-1)/CXCR4 are involved in lymphocyte activation
(step 2; references 48–51). Firm adhesion of lymphocytes
to the endothelium is mediated by  4 7/MAdCAM-1 and
LFA-1 (step 3; reference 3). The molecules that mediate
diapedesis (step 4) into the PP include CXCL13 (BLC) and
its receptor CXCR5 (49).
By analogy with these events in PP, our results suggest a
model in which lymphocytes tether and roll on BALT
HEVs by lymphocyte L-selectin binding to carbohydrate
epitopes on endothelial PNAd and by lymphocyte  4 1T
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1265 Xu et al.
binding to VCAM-1 (step 1).  4 1/VCAM-1 interactions
may slow rolling cells, which arrest on BALT endothelium
through activation-dependent  4 1/VCAM-1 and LFA-1–
mediated firm adhesion (step 3). The molecules that medi-
ate lymphocyte activation (step 2) and diapedesis into
BALT (step 4) remain to be defined.
In BALT as in PP, specific lymphocyte subsets may be
able to migrate into tissue using only some of the adhe-
sion molecules that are available in their cascade. For ex-
ample, memory T cells might tether and roll (step 1) on
BALT HEVs using  4 1 and VCAM-1, instead of L-selec-
tin and PNAd. Thus, by analogy to the efficient homing
of  4 7
  memory T cells through MAdCAM-1  HEVs
in PP, the availability of VCAM-1 on BALT HEVs may
be important in recruitment of  4 1
  memory T cells
into BALT. In contrast, we found that anti-PNAd mAb,
but not mAbs against  4 and VCAM-1, blocks migration
of naive T cells into BALT. This suggests that these naive
cells may be able to tether and roll on HEVs without us-
ing  4 1 and VCAM-1, instead relying on lymphocyte
L-selectin binding to the PNAd that is highly expressed
on BALT HEVs.
Potential Significance of BALT in Pulmonary Immune Re-
sponses. Striking similarities between BALT and PP sup-
port the concept that these tissues have parallel physiologic
and pathologic roles in pulmonary and intestinal immunity,
respectively (7). The epithelial surface over PP contains M
cells that mediate the transport of antigens from the intesti-
nal lumen into PP. PPs also support the migration of naive
T and B lymphocytes from the blood via HEV. Thus, PPs
provide a microenvironment for activation and initial dif-
ferentiation of naive lymphocytes responding to intestinal
antigens. After further maturation in the MLN, the lym-
phocytes enter the systemic circulation, where they com-
prise a population of  4 7
  memory cells that display selec-
tive, efficient migration to intestinal sites such as PP and
lamina propria (6). Adhesion cascades, in which  4 7 and
MAdCAM-1 play prominent tissue-selective roles, mediate
this homing of lymphocytes to intestine. Thus,  4 7 and
MAdCAM-1 unify lymphocyte migration to intestinal sec-
ondary lymphoid tissues (PP) and effector sites (lamina pro-
pria; references 3, 16, 22).
BALT is thought to function as the primary site for pre-
sentation of airway antigens to the immune system. Here,
we show that BALT HEVs support the migration of naive
T cells from blood into BALT, where these lymphocytes
can encounter antigens that have been transported from the
airway lumen by bronchial M cells. After maturation in
BALT and/or bronchial LN, these lymphocytes could en-
ter the bloodstream, where they would comprise a recircu-
lating population of  4 1
  memory cells for respiratory
tract antigens. These memory lymphocytes would migrate
efficiently from blood into BALT and other bronchopul-
monary tissues using adhesion cascades in which  4 1 and
VCAM-1 contribute prominently to tissue selectivity.
Thus,  4 1 and VCAM-1 may help unify lymphocyte mi-
gration to bronchopulmonary secondary lymphoid tissues
(BALT) and effector sites (lung).
In conclusion, we found that most BALT HEVs coordi-
nately express the endothelial adhesion molecules PNAd
and VCAM-1, the latter at a level not seen on HEVs in
other secondary lymphoid tissues. Moreover, lymphocyte
homing to BALT involves prominent participation of
L-selectin/PNAd,   4 1/VCAM-1, and LFA-1 adhesion
pathways. We propose that these receptor/ligand pairs par-
ticipate in a specialized adhesion cascade that regulates the
interactions of circulating lymphocytes with BALT HEVs,
and that allows the targeting of naive and memory T cells
to these airway secondary lymphoid tissues. The shared
participation of  4 1/VCAM-1 in BALT and in pulmo-
nary parenchymal recruitment of lymphocytes provides a
mechanism to unite migration pathways, and thus immune
responses, in BALT and lung.
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